Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Kevin Clarke who wrote (4183)	9/22/1998 9:17:00 PM
From: OFW	Read Replies (1) \| Respond to of 5402

Agree with Prospector. In the AHN interview, he came across as very, very smooth, professional and down-to-earth --- almost like a kind of guy you would want to sit down with over a cup of coffee and discuss his products. It was obvious to me that he felt at home discussing the medical aspects and the research end of it more than he was discussing the business and investment end of it as was the focus on CnnFn. No question, AHN was more favorable to the product. The CnnFn show, regretfully, did not really focus on the product itself. The big question now is what media outlets might pick up on the story and run with it from this point. Perhaps some medical reporters with CNN might pick it up - maybe we should email to CNN suggesting it as a story. Offie